Ted Love

Ted Love

Directeur/Membre du Conseil chez GILEAD SCIENCES, INC.

Fortune : 4 M $ au 31/05/2026

67 ans
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Ted W.
Love
, MD, is an Independent Director at Gilead Sciences, Inc., an Independent Director at Structure Therapeutics, Inc. and a Lead Independent Director at Royalty Pharma Plc.
He is on the Board of Directors at Jazz Pharmaceuticals Plc, Gilead Sciences, Inc., Structure Therapeutics, Inc., Royalty Pharma Plc, Avillion LLP, Biotechnology Innovation Organization and Life Science Cares Bay Area.
Dr. Love was previously employed as an Independent Director by Seagen, Inc., an Independent Director by Portola Pharmaceuticals LLC, a President, Chief Executive Officer & Director by Global Blood Therapeutics, Inc., an Independent Director by CASCADIAN THERAPEUTICS INC, an Independent Director by Mast Therapeutics, Inc., an Independent Director by Amicus Therapeutics, Inc., an Independent Director by Bio-Rad Laboratories, Inc., an Executive VP, Head-Research & Development by Onyx Pharmaceuticals, Inc., a Lead Independent Director by KaloBios Pharmaceuticals, Inc., an Independent Director by Affymax, Inc., an Independent Director by Santarus, Inc., a Chairman, President & Chief Executive Officer by Nuvelo, Inc., a Senior Vice President-Development by Theravance, Inc., a Senior Vice President-Development by Theravance Biopharma Us LLC, and a VP-Product Development & Regulatory Affairs by Genentech, Inc. He also served on the board at Anesiva, Inc., ARCA biopharma, Inc., California Institute for Regenerative Medicine, ARCA biopharma, Inc. /Old/, California Healthcare Institute, Predix Pharmaceuticals, Inc., Stanford Health Care-Stanford Hospital and The Biotechnology Institute.
He received his undergraduate degree from Haverford College and a doctorate degree from Yale School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/06/2026 58 393 ( 0,01 % ) 3 M $ 31/05/2026
30/04/2026 5 484 ( 0 % ) 737 214 $ 31/05/2026
26/02/2026 1 527 ( 0 % ) 361 120 $ 31/05/2026
20/04/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Ted Love

SociétésPosteDébut
ROYALTY PHARMA PLC Directeur/Membre du Conseil 30/07/2020
STRUCTURE THERAPEUTICS INC. Directeur/Membre du Conseil 03/08/2023
GILEAD SCIENCES, INC. Directeur/Membre du Conseil 01/02/2024
JAZZ PHARMACEUTICALS PLC Directeur/Membre du Conseil 01/12/2025
Life Science Cares Bay Area
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/01/2025
Directeur/Membre du Conseil 22/07/2013

Anciens postes connus de Ted Love

SociétésPosteFin
SEAGEN INC. Directeur/Membre du Conseil 14/12/2023
GLOBAL BLOOD THERAPEUTICS, INC. Directeur Général 05/10/2022
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Ted Love

Formation de Ted Love

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

73

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Government

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Life Science Cares Bay Area

Commercial Services

- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇